NUPATHE INC.

Profile

Company Names

NUPATHE INC.

Addresses

227 WASHINGTON STREET, SUITE 200, CONSHOHOCKEN, PA 19428

Phone Numbers

484-567-0130

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$39,162,500.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-10-23 
$28,000,000.00 
$28,000,000.00 
$0.00 
Equity 
2
2011-08-02 
$1,100,000.00 
$30,600,000.00 
$29,500,000.00 
Equity 
1
2010-04-09 
$10,062,500.00 
$10,062,500.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARMANDO 
 
ANIDO 
EXECUTIVE OFFICER, DIRECTOR
NUPATHE INC.   |  AURIS MEDICAL HOLDING AG
MICHAEL 
 
COLA 
DIRECTOR
NUPATHE INC.   |  SENDERO BIOTECHNOLOGY, INC.   |  CYBIN INC.
MICHAEL 
F. 
COLA 
DIRECTOR
NUPATHE INC.   |  MEDGENICS, INC.   |  AEVI GENOMIC MEDICINE, INC.   |  SAGE THERAPEUTICS, INC.
JEANNE 
 
CUNICELLI 
DIRECTOR
CALYPSO MEDICAL TECHNOLOGIES INC   |  INSPIRED TECHNOLOGIES INC   |  IDEV TECHNOLOGIES INC   |  NUPATHE INC.   |  ALUNG TECHNOLOGIES INC   |  TCXPRESS, INC.   |  GENERIAN PHARMACEUTICALS, INC.   |  BLUESPHERE BIO, INC.   |  NOVASENTA INC.
JAMES 
A. 
DATIN 
DIRECTOR
CLARIENT, INC   |  QUINNOVA PHARMACEUTICALS, INC.   |  NOVASOM, INC   |  PUTNEY INC   |  NUPATHE INC.   |  BALX HOLDINGS, LLC
MICHAEL 
C. 
DIEM 
DIRECTOR
TRINITY BIOSYSTEMS INC   |  NUPATHE INC.
JOHN 
H. 
DILLON, II 
DIRECTOR
NUPATHE INC.
BART 
J. 
DUNN 
EXECUTIVE OFFICER
NUPATHE INC.
WILLIAM 
J. 
FEDERICI 
DIRECTOR
NUPATHE INC.
EZRA 
H. 
FELKER 
EXECUTIVE OFFICER
NUPATHE INC.
KEITH 
A. 
GOLDAN 
EXECUTIVE OFFICER
NUPATHE INC.   |  FIBROCELL SCIENCE, INC.   |  OPTINOSE, INC.
SUZANNE 
M. 
HANLON 
EXECUTIVE OFFICER
NUPATHE INC.
JANE 
H. 
HOLLINGSWORTH 
DIRECTOR, EXECUTIVE OFFICER
NUPATHE INC.   |  IMMUNOME INC.
RICHARD 
S. 
KOLLENDER 
DIRECTOR
TRANSPORT PHARMACEUTICALS INC   |  TRANSAVE INC   |  PRECISION THERAPEUTICS INC   |  NUPATHE INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  CELATOR PHARMACEUTICALS INC   |  OCUGENIX CORP
GARY 
J. 
KURTZMAN 
DIRECTOR
AVID RADIOPHARMACEUTICALS, INC.   |  NUPATHE INC.   |  NEW LIFE SOLUTION, INC.
MICHAEL 
F. 
MARINO 
EXECUTIVE OFFICER
NUPATHE INC.   |  FIBROCELL SCIENCE, INC.   |  OPTINOSE, INC.
GERALD 
W. 
MCLAUGHLIN 
EXECUTIVE OFFICER
NUPATHE INC.   |  AGENEBIO, INC.   |  NEMUS BIOSCIENCE, INC.
ROBERT 
P. 
ROCHE 
DIRECTOR
NUPATHE INC.
TERRI 
B. 
SEBREE 
EXECUTIVE OFFICER
NUPATHE INC.   |  ZYNERBA PHARMECEUTICALS, INC.
BRIAN 
J. 
SISKO 
DIRECTOR
NUPATHE INC.
WAYNE 
P. 
YETTER 
DIRECTOR
NUPATHE INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-11-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-23 
2011-08-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-08-02 
2010-04-23
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2010-04-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
LEERINK SWANN LLC
39011
LEERINK SWANN LLC
39011
MTS SECURITIES, LLC
104059
MTS SECURITIES, LLC
104059